McAllen TX 黄斑变性临床试验
6项针对 黄斑变性的研究正在 McAllen及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
招募中1/2 期
- Valley Retina Institute, PA, McAllen
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
招募中3 期
- Valley Retina Institute, P.A., McAllen
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
招募中2 期
- Valley Retina Institute, P.A., McAllen
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
招募中1/2 期
- Valley Retina Institute, PA, McAllen
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
招募中1/2 期
- McAllen, TX, McAllen
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
招募中观察性研究欢迎健康志愿者
- Valley Retina Institute, McAllen
其他城市的 黄斑变性试验
- Dallas, TX13 项研究
- Erie, PA10 项研究
- The Woodlands, TX9 项研究
- Sacramento, CA8 项研究
- Hagerstown, MD8 项研究
- Reno, NV8 项研究
- Phoenix, AZ7 项研究
- Cleveland, OH7 项研究
- Houston, TX7 项研究
- Salt Lake City, UT7 项研究
- Boston, MA7 项研究
- Austin, TX7 项研究
McAllen的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。